🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "focused action to deal with cost of living pressures" in the upcoming financial statement.

During an interview with media outlets, she emphasized that lowering inflation is a joint duty of both the government and the Bank of England.

The UK's inflation rate is expected to be the highest among the G7 advanced economies this calendar year and the following year.

Potential Energy Bill Interventions

It is understood the government could take action to bring down utility costs, for example by slashing the current 5% level of VAT applied on energy.

An additional possibility is to reduce some of the government charges currently added to bills.

Fiscal Limitations and Expert Expectations

The administration will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for such actions.

The expectation from the majority of experts is that the Chancellor will have to announce tax rises or spending cuts in order to adhere to her declared fiscal targets.

Earlier on the same day, analysis showed there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the lower end of expectations.

"It is a joint task between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor informed reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and International Concerns

While much of the attention has been on likely tax rises, the chancellor said the latest information from the fiscal watchdog had not changed her vow to election pledges not to increase tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with growing international and trade tensions for the Budget revenue measures, probably to be targeted on those "wealthiest."

Global Trade Tensions

Addressing concerns about the UK's commercial links with the Asian nation she said: "Our national security always take priority."

Recent statement by China to increase trade restrictions on rare earths and other materials that are key for advanced tech manufacturing led US President Donald Trump to propose an extra 100% tariff on goods from China, increasing the risk of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a global supply chain power grab."

Inquired about considering the American proposal to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the global economy and creates additional challenges."

"I believe there are areas where we should confront Chinese policies, but there are also important prospects to sell into China's economy, including financial services and other areas of the economy. We've got to achieve that balance right."

The chancellor also affirmed she was cooperating with other major economies "regarding our own essential resources approach, so that we are more independent."

NHS Medicine Costs and Investment

Reeves also recognized that the price the National Health Service spends on pharmaceuticals could increase as a consequence of current negotiations with the Trump administration and its drugs companies, in exchange for reduced taxes and funding.

A number of the world's largest drug companies have said recently that they are either halting or abandoning investments in the UK, with several attributing the insufficient payments they are receiving.

Last month, the government science advisor said the cost the health service pays for medicines would need to go up to prevent companies and pharmaceutical investment departing from the UK.

Reeves told the BBC: "It has been observed because of the cost structure, that drug testing, innovative medicines have not been provided in the United Kingdom in the manner that they are in other European countries."

"The objective is to make sure that patients receiving care from the National Health Service are can receive the best life-saving drugs in the world. And so we are reviewing all of that, and... looking to attract increased funding into Britain."